Iovance Biotherapeutics
American biopharmaceutical startup
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 9 annual filings
Revenue
$263.50M
Net Income
-$390.98M
Assets
$913.17M
EPS (diluted)
$-1.09
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001104659-26-018899Iovance Biotherapeutics
Summary
Iovance Biotherapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (288 views/month).[2]
Key Facts
- Iovance Biotherapeutics is in the country of United States[3].
- Iovance Biotherapeutics is in the country of US[4].
- Iovance Biotherapeutics's instance of is recorded as business[5].
- Iovance Biotherapeutics's instance of is recorded as public company[6].
- Iovance Biotherapeutics's headquarters location is recorded as San Carlos[7].
- Iovance Biotherapeutics's stock exchange is recorded as Nasdaq[8].
- Iovance Biotherapeutics's industry is recorded as pharmaceutical industry[9].
- 2007 marks the founding of Iovance Biotherapeutics[10].
- 2017-06-01 marks the founding of Iovance Biotherapeutics[11].
- Iovance Biotherapeutics's official website is recorded as http://www.iovance.com/[12].
- Iovance Biotherapeutics's legal form is recorded as XTIQ[13].
Body
Founding
Recorded inception include 2007[10] and 2017-06-01[11].
Operations
Iovance Biotherapeutics's headquarters location is recorded as San Carlos[7].
Industry
Iovance Biotherapeutics's industry is recorded as pharmaceutical industry[9].
Ownership
Iovance Biotherapeutics's stock exchange is recorded as Nasdaq[8].
Why It Matters
Iovance Biotherapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (288 views/month).[2]